Lurleen Benzian in Santa Barbara, California

Home California Santa Barbara

Lurleen Benzian has Dermatology as her primary medical specialty. Their primary office is: 334 S Patterson Ave in Santa Barbara, California. There is an additional office location, for a total of two, for Lurleen Benzian that can be viewed further down. They attended Jc Edwards School Of Medicine, Marshall University and graduated in 1991 (around 33 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Lurleen R Benzian Office Phone and Directions

Lurleen Benzian
334 S Patterson Ave
Santa Barbara, California 93111
805-964-1514

Patient Ratings
Please rate your experience with Lurleen Benzian below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 805-964-1514

Enter a starting address:

Healthcare Info for Lurleen Benzian

Medical School: Jc Edwards School Of Medicine, Marshall University
Graduation Year: 1991
The Primary Medical Specialty for Lurleen Benzian is listed as: Dermatology
Approximate Years of Experience: 33
PAC (PECOS ID)#: 8820113400
NPI #: 1639173289
NPI Created On: 06/10/2005
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207N00000X
License Number:
G82200
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs
Shaving of 0.6 centimeters to 1.0 centimeters skin growth of scalp, neck, hands, feet, or genitals
Shaving of 0.5 centimeters or less skin growth of face, ears, eyelids, nose, lips, or mouth
Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of 15 or more skin growths
Destruction of up to 14 skin growths
Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals
Destruction of malignant growth (0.5 centimeters or less) of face, ears, eyelids, nose, lips, or mouth
Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
Pathology examination of tissue using a microscope, intermediate complexity
New patient office or other outpatient visit, typically 30 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809559341

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: INFLAMMATION AND IMMUNOLOGY

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01